fluracedyl 50 mg/ml injektionslösung
teva pharma belgium - fluorouracil - injektionslösung - 50 mg/ml - fluorouracil 5000 mg - fluorouracil
uft hartkapseln
eurimpharm arzneimittel gmbh (8050167) - tegafur; uracil - hartkapsel - tegafur (12295) 100 milligramm; uracil (6428) 224 milligramm
uft hartkapseln
emra-med arzneimittel gmbh (3263935) - tegafur; uracil - hartkapsel - tegafur (12295) 100 milligramm; uracil (6428) 224 milligramm
uft hartkapseln
cc-pharma gmbh (8029457) - tegafur; uracil - hartkapsel - tegafur (12295) 100 milligramm; uracil (6428) 224 milligramm
uft hartkapseln
orifarm gmbh (3237116) - tegafur; uracil - hartkapsel - tegafur (12295) 100 milligramm; uracil (6428) 224 milligramm
uft hartkapseln
kohlpharma gmbh (3216120) - tegafur; uracil - hartkapsel - tegafur (12295) 100 milligramm; uracil (6428) 224 milligramm
uft hartkapseln
medicopharm ag arzneimittel & medikal produkte (8021444) - tegafur; uracil - hartkapsel - tegafur (12295) 100 milligramm; uracil (6428) 224 milligramm
benda-5 fu
bendalis gmbh (8086604) - fluorouracil - injektionslösung - teil 1 - injektionslösung; fluorouracil (07374) 50 milligramm
teysuno
nordic group b.v. - tegafur, gimeracil, oteracil - magen-neoplasmen - antineoplastische mittel - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.
uft - kapseln
merck gesellschaft mbh - uracil,tegafur - tegafur, kombinationen